MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.
Hong X, Xu Y, Qiu X, Zhu Y, Feng X, Ding Z, Zhang S, Zhong L, Zhuang Y, Su C, Hong X, Cai J.
Hong X, et al. Among authors: ding z.
Oncotarget. 2016 Apr 19;7(16):22092-102. doi: 10.18632/oncotarget.8020.
Oncotarget. 2016.
PMID: 26989077
Free PMC article.